|Bid||112.00 x 0|
|Ask||116.00 x 0|
|Day's range||108.60 - 128.87|
|52-week range||0.88 - 195.00|
|Beta (5Y monthly)||1.70|
|PE ratio (TTM)||N/A|
|Earnings date||07 Aug 2019|
|Forward dividend & yield||N/A (N/A)|
|1y target est||70.00|
As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...
Finding stocks that have both positive share price momentum and improving financial health trends is a great way of finding pockets of quality and momentum in8230;
Carl Sterritt became the CEO of Shield Therapeutics plc (LON:STX) in 2008. This analysis aims first to contrast CEO...